Acorda Therapeutics Inc Accounts Receivables Turnover Ratio from the first quarter 2024 to the first quarter 2023

Quarterly Results, Trends, Rankings, Statistics

Acorda Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 8.92, indicating more challenging environment then in the fourth quarter 2023, but still, it is a far cry from any concerns. Acorda Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 41 days, from 40 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 298 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2209, from overall ranking in the fourth quarter 2023 at 2477.

What is Receivable Turnover Ratio?
What is Acorda Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACORQ Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	-0.02 %	24.75 %	-18.47 %	-6.17 %	-23.35 %
Y / Y Revenue Change	-8.85 %	20.7 %	-17.3 %	-4.43 %	-1.22 %
Receivable Turnover Ratio (TTM)	8.92	9.07	9.18	9.15	9.1
ACORQ's Total Ranking	# 2209	# 2477	# 2477	# 2481	#
Accounts Receivable average collection period days	41	40	40	40	40
Seq. Receivable Change	-46.88 %	44.43 %	-10.55 %	45.7 %	-33.72 %
Seq. Revenue Change	-46.59 %	37.06 %	-6.6 %	33.32 %	-29.27 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 13
Healthcare Sector	# 299
Overall Market	# 2209

Receivable Turnover Ratio Statistics
High	Average	Low
0.84	0.43	0.19
(Sep 30 2011)		(Dec 31 2019)

ACORQ Company Profile • Back to ACORQ Efficiency Comparisons • Compare ACORQ Receivables Turnover Ratio to its Competitors

Financial Statements
Acorda Therapeutics Inc 's Accounts Receivable	$ 9 Millions	Visit ACORQ's Balance sheet
Acorda Therapeutics Inc 's Sales TTM	$ 116 Millions	Visit ACORQ's Income Statement
Sources of ACORQ's Revenues		Visit ACORQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACORQ's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACORQ's Growth Rates	ACORQ's Roa	ACORQ's Inventory Turnover Ratio	ACORQ's Dividend Comparisons
ACORQ's Profitability Ratios	ACORQ's Roi	ACORQ's Asset Turnover Ratio	ACORQ's Dividend Growth
ACORQ's Valuation Ratios	ACORQ's Roe	ACORQ's Financial Strength Ratios	ACORQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Invo Fertility Inc	33.38	$ 4.249 Millions	$ 0.127 Millions
Prothena Corporation Public Limited Company	32.93	$ 89.251 Millions	$ 2.710 Millions
Lifemd Inc	32.84	$ 161.635 Millions	$ 4.922 Millions
23andme Holding Co	32.38	$ 219.377 Millions	$ 6.776 Millions
Sonida Senior Living Inc	30.60	$ 260.687 Millions	$ 8.518 Millions
Fortrea Holdings Inc	28.62	$ 3,006.900 Millions	$ 105.050 Millions
Sab Biotherapeutics Inc	28.59	$ 2.602 Millions	$ 0.091 Millions
Neuroone Medical Technologies Corp	26.83	$ 3.727 Millions	$ 0.139 Millions
Cv Sciences Inc	26.71	$ 14.790 Millions	$ 0.554 Millions
National Vision Holdings Inc	26.61	$ 2,106.622 Millions	$ 79.168 Millions
Ainos Inc	26.44	$ 0.094 Millions	$ 0.004 Millions
Scorpius Holdings inc	26.26	$ 9.743 Millions	$ 0.371 Millions
Clearside Biomedical Inc	25.87	$ 8.452 Millions	$ 0.327 Millions
Inmed Pharmaceuticals Inc	25.66	$ 6.218 Millions	$ 0.242 Millions
Anika Therapeutics Inc	25.46	$ 167.792 Millions	$ 6.590 Millions
Embecta Corp	25.37	$ 1,130.400 Millions	$ 44.550 Millions
Aquestive Therapeutics Inc	24.32	$ 51.502 Millions	$ 2.118 Millions
Innoviva Inc	23.99	$ 327.565 Millions	$ 13.655 Millions
Innovage Holding Corp	22.93	$ 741.328 Millions	$ 32.333 Millions
Cytomx Therapeutics Inc	22.78	$ 119.178 Millions	$ 5.233 Millions
Agenus Inc	22.51	$ 161.417 Millions	$ 7.171 Millions
U S Physical Therapy Inc	22.47	$ 611.968 Millions	$ 27.240 Millions
Bespoke Extracts Inc	21.68	$ 0.957 Millions	$ 0.044 Millions
Cybin Inc	21.52	$ 71.130 Millions	$ 3.306 Millions
Fortress Biotech Inc	21.30	$ 85.114 Millions	$ 3.996 Millions
Kymera Therapeutics Inc	21.18	$ 79.413 Millions	$ 3.750 Millions
Orchestra Biomed Holdings Inc	20.96	$ 2.216 Millions	$ 0.106 Millions
Zomedica Corp	20.59	$ 24.953 Millions	$ 1.212 Millions
Zivo Bioscience Inc	19.47	$ 0.063 Millions	$ 0.003 Millions
Jrsis Health Care Corp	19.12	$ 3.962 Millions	$ 0.207 Millions

Date modified: 2026-10-07T00:41:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.